191 related articles for article (PubMed ID: 22304369)
1. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.
Kitano M; Rahbari R; Patterson EE; Steinberg SM; Prasad NB; Wang Y; Zeiger MA; Kebebew E
Thyroid; 2012 Mar; 22(3):285-91. PubMed ID: 22304369
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
[TBL] [Abstract][Full Text] [Related]
3. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
5. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.
Shen R; Liyanarachchi S; Li W; Wakely PE; Saji M; Huang J; Nagy R; Farrell T; Ringel MD; de la Chapelle A; Kloos RT; He H
Thyroid; 2012 Jan; 22(1):9-16. PubMed ID: 22136206
[TBL] [Abstract][Full Text] [Related]
7. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs.
Kitano M; Rahbari R; Patterson EE; Xiong Y; Prasad NB; Wang Y; Zeiger MA; Kebebew E
Ann Surg Oncol; 2011 Nov; 18(12):3443-52. PubMed ID: 21553140
[TBL] [Abstract][Full Text] [Related]
9. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
[TBL] [Abstract][Full Text] [Related]
10. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
[TBL] [Abstract][Full Text] [Related]
11. Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules.
Kaliszewski K; Diakowska D; Wojtczak B; Strutyńska-Karpińska M; Domosławski P; Sutkowski K; Głód M; Balcerzak W; Forkasiewicz Z; Łukieńczuk T
PLoS One; 2016; 11(1):e0146883. PubMed ID: 26784518
[TBL] [Abstract][Full Text] [Related]
12. IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?
Lupo M; Guttler R; Geck Z; Tonozzi TR; Kammesheidt A; Braunstein GD
Endocr Pract; 2018 May; 24(5):453-459. PubMed ID: 29498908
[TBL] [Abstract][Full Text] [Related]
13. UTILITY OF ULTRASOUND VERSUS GENE EXPRESSION CLASSIFIER IN THYROID NODULES WITH ATYPIA OF UNDETERMINED SIGNIFICANCE.
Villabona CV; Mohan V; Arce KM; Diacovo J; Aggarwal A; Betancourt J; Amer H; Jose T; DeSantis P; Cabral J
Endocr Pract; 2016 Oct; 22(10):1199-1203. PubMed ID: 27409819
[TBL] [Abstract][Full Text] [Related]
14. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
15. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger.
Pinchot SN; Al-Wagih H; Schaefer S; Sippel R; Chen H
Arch Surg; 2009 Jul; 144(7):649-55. PubMed ID: 19620545
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
[No Abstract] [Full Text] [Related]
18. Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples.
Zhang Y; Zhong Q; Chen X; Fang J; Huang Z
Tumour Biol; 2014 Sep; 35(9):9343-53. PubMed ID: 24943685
[TBL] [Abstract][Full Text] [Related]
19. The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules.
Sidoti M; Marino G; Resmini E; Augeri C; Cappi C; Cavallero D; Lagasio C; Ceppa P; Minuto F; Giusti M
Minerva Endocrinol; 2006 Jun; 31(2):159-72. PubMed ID: 16682939
[TBL] [Abstract][Full Text] [Related]
20. PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.
Halászlaki C; Tóbiás B; Balla B; Kósa JP; Horányi J; Bölöny E; Nagy Z; Speer G; Járay B; Székely E; Istók R; Székely T; Putz Z; Dank M; Lakatos P; Takács I
Endocr Pract; 2016 Sep; 22(9):1081-7. PubMed ID: 27214302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]